iDiD: Intervention for Improving Psychological Distress in Dialysis

Sponsor
King's College London (Other)
Overall Status
Completed
CT.gov ID
NCT02352870
Collaborator
National Health Service, United Kingdom (Other), University of Southampton (Other)
25
1
2
16
1.6

Study Details

Study Description

Brief Summary

To explore whether it is feasible to recruit and retain haemodialysis patients into a randomised controlled trial of online cognitive-behavioural therapy to manage distress

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Computerised Cognitive Behavioural Therapy
  • Behavioral: Telephone support
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
25 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Intervention for Improving Psychological Distress in Dialysis (iDiD) Feasibility Two Arm Randomised Controlled Trial: Online Cognitive Behavioural Therapy (CBT) Intervention With Therapist Support vs Online CBT Intervention Alone (no Therapist Support)
Study Start Date :
Feb 1, 2015
Actual Primary Completion Date :
Jun 1, 2016
Actual Study Completion Date :
Jun 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Computerised CBT with therapist support

Participants complete seven online cognitive behavioural therapy sessions weekly plus they receive three telephone support calls. The content of each of the sessions are summarised below: Session 1: Psycho-education about end-stage renal failure Session 2: Generation of CBT "hot cross bun" model of psychological distress Session 3: Coping strategies for managing negative emotions, including: acceptance, relaxation, expression and tips for improving sleep quality. Session 4: Identifying and challenging unhelpful thoughts Session 5: Goal setting and problem solving Session 6: Managing difficult social relationships Session 7: Progress recap and preparing for the future In addition to completing the seven online sessions the intervention arm received three 30 minute telephone support calls at weeks two, four, and six to facilitate engagement and understanding of the contents of the website.

Behavioral: Computerised Cognitive Behavioural Therapy
Online treatment sessions are scheduled to last approximately one hour, completed independently by the participant on a weekly basis

Behavioral: Telephone support
Telephone support calls are scheduled to last 30 minutes and and are received fortnightly at weeks: 2, 4 and 6.

Active Comparator: Computerised CBT without therapist support

Participants complete seven online cognitive behavioural therapy sessions weekly but do not receive any telephone support calls. The content of each of the sessions are summarised below: Session 1: Psycho-education about end-stage renal failure Session 2: Generation of CBT "hot cross bun" model of psychological distress Session 3: Coping strategies for managing negative emotions, including: acceptance, relaxation, expression and tips for improving sleep quality. Session 4: Identifying and challenging unhelpful thoughts Session 5: Goal setting and problem solving Session 6: Managing difficult social relationships Session 7: Progress recap and preparing for the future

Behavioral: Computerised Cognitive Behavioural Therapy
Online treatment sessions are scheduled to last approximately one hour, completed independently by the participant on a weekly basis

Outcome Measures

Primary Outcome Measures

  1. Consent to psychological screen rate using self-report measures of depression (PHQ-9) and anxiety (GAD-7) [Baseline recruitment/screening]

    Record the number of patients approached for screening and their consent rate

Secondary Outcome Measures

  1. Recruitment , randomisation, and retention rates [Screening, baseline, and 12 weeks follow-up]

    Descriptive statistics as per CONSORT flow diagram

  2. Adherence to the online intervention + telephone support calls (therapist supported arm only) [12 weeks follow-up]

    Number of online sessions accessed and their duration + number of calls completed and their duration (therapist supported arm only)

  3. PHQ-9 (A self-report 9 item measure of depression) [Change in depression from baseline to 12 weeks]

    A self-report 9 item measure of depression

  4. GAD-7 (A self-report 7 item measure of anxiety) [Change in anxiety from baseline to 12 weeks]

    A self-report 7 item measure of anxiety

  5. EQ-5D (A self-report measure of quality of life) [Baseline and 12 weeks follow-up]

    A self-report measure of quality of life

  6. Brief Illness Perceptions Questionnaire [Baseline and 12 weeks follow-up]

    A self-report measure of beliefs about illness

  7. Client Service Receipt Inventory (A self-report measure of health service utilisation) [Baseline and 12 weeks follow-up]

    A self-report measure of health service utilisation

  8. Satisfaction with treatment (A 2 item measure generated for the purposes of present study) [Baseline and 12 weeks follow-up]

    A 2 item measure generated for the purposes of present study

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Aged 18 years or over and receive hospital haemodialysis three-times weekly

  2. Presence of mild to moderately severe depressive symptoms (based on PHQ-9 scores of 5 to 19 in range; a self-report measure of depression) and/or presence of mild to moderate anxiety symptoms (based on GAD-7 scores of 5-14)

  3. Speak English sufficiently well to engage with screening tools

  4. Have a basic understanding of how to use the Internet and an email address

  5. Have a minimum dialysis vintage of ≥3 months (electronic patient record)

Exclusion Criteria:
  1. Hospitalised at the time of assessment or within 1 month prior to the assessment

  2. Currently receiving active treatment for depression and/or anxiety. We consider active treatment to be any current psychological treatments (talking therapies) or receipt of a new anti-depressant and/or anti-anxiety medication. A medication is considered new if it is commenced three months prior to the completion of the depression and anxiety screening questionnaire

  3. Severe mental health disorders, for example, psychosis, bi-polar disorder

  4. Active suicidal thoughts-any participant that scores greater than one on the depression PHQ-9 item "Thoughts that you would be better off dead, or of hurting yourself" will be excluded from the study.

  5. Evidence of addiction to alcohol or drugs

Contacts and Locations

Locations

Site City State Country Postal Code
1 Guy's and St Thomas NHS Trust London United Kingdom SE1 9RT

Sponsors and Collaborators

  • King's College London
  • National Health Service, United Kingdom
  • University of Southampton

Investigators

  • Principal Investigator: Joseph Chilcot, PhD, King's College London

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
King's College London
ClinicalTrials.gov Identifier:
NCT02352870
Other Study ID Numbers:
  • PAHTMZA WPAH 68913
  • 14.LO.1934
First Posted:
Feb 2, 2015
Last Update Posted:
Oct 10, 2017
Last Verified:
Sep 1, 2015
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by King's College London
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 10, 2017